The treatment of malaria

New England Journal of Medicine

Volumn 335, Issue 11, 1996, Pages 800-806

  White, N J ^a,b,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHO QUAN HOSPITAL   (Viet Nam)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMETHER; ARTESUNATE; CHLOROQUINE; CLINDAMYCIN; FANSIDAR; HALOFANTRINE; MEFLOQUINE; PRIMAQUINE; QUINIDINE; QUININE; TETRACYCLINE;

CONSCIOUSNESS DISORDER; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DYSPHORIA; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOGLYCEMIA; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALARIA; METHEMOGLOBINEMIA; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME; TREATMENT PLANNING;

AGE FACTORS; CHILD; DEMOGRAPHIC FACTORS; DEVELOPING COUNTRIES; DISEASES; DRUGS--THERAPEUTIC USE; LITERATURE REVIEW; MALARIA--PREVENTION AND CONTROL; PARASITIC DISEASES; POPULATION; POPULATION CHARACTERISTICS; PREGNANT WOMEN; SIGNS AND SYMPTOMS; TREATMENT--CONTRAINDICATIONS; YOUTH;

ADULT; ANTIMALARIALS; ARTEMISININS; CHILD; CHLOROQUINE; DRUG RESISTANCE; FEMALE; HUMANS; MALARIA; MALARIA, FALCIPARUM; PREGNANCY; PROGNOSIS; SESQUITERPENES;

EID: 0029792910     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199609123351107     Document Type: Review

References (49)

1. Field JW. The morphology of malarial parasites in thick blood films. IV. The identification of species and phase. Trans R Soc Trop Med Hyg 1941; 34:405-14.
2. Phu NH, Day NPJ, Diep PT, Ferguson DJP, White NJ. Intraleucocytic malaria pigment and prognosis in severe malaria. Trans R Soc Trop Med Hyg 1995;89:200-4.
3. Beadle C, Long GW, Weiss WR, et al. Diagnosis of malaria by detection of Plasmodium falciparum HRP-2 antigen with a rapid dipstick antigen-capture assay. Lancet 1994;343:564-8.
4. Bruce-Chwatt LJ, ed. Chemotherapy of malaria. 2nd ed. World Health Organization monograph series no. 27. Geneva: World Health Organization, 1981.
5. Rieckmann KH, Davis DR, Hutton DC. Plasmodium vivax resistance to chloroquine? Lancet 1989;2:1183-4.
6. Murphy GS, Basri H, Purnomo, et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 1993;341:96-100.
7. Davis TME, Supanaranond W, Pukrittayakamee S, et al. A safe and effective consecutive-infusion regimen for rapid quinine loading in severe falciparum malaria. J Infect Dis 1990;161:1305-8.
8. Pussard E, Lepers JP, Clavier F, et al. Efficacy of a loading dose of oral chloroquine in a 36-hour treatment schedule for uncomplicated Plasmodium falciparum malaria. Antimicrob Agents Chemother 1991;35:406-9.
9. Watkins WM, Sixsmith DG, Spencer HC, et al. Effectiveness of amodiaquine as treatment for chloroquine-resistant Plasmodium falciparum infections in Kenya. Lancet 1984;1:357-9.
10. Kremsner PG. Clindamycin in malaria treatment. J Antimicrob Chemother 1990;25:9-14.
11. Palmer KJ, Holliday SM, Brogden RN. Mefloquine: a review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1993;45:430-75.
12. Phillips-Howard PA, ter Kuile FO. CNS adverse events associated with antimalarial agents: fact or fiction? Drug Saf 1995;12:370-83.
13. ter Kuile FO, Luxemburger C, Nosten F, et al. Mefloquine treatment of acute falciparum malaria; a prospective study of nonserious adverse effects in 3,673 patients. Trans R Soc Trop Med Hyg 1996;73:631-42.
14. ter Kuile FO, Nosten F, Thieren M, et al. High-dose mefloquine in the treatment of multidrug-resistant falciparum malaria. J Infect Dis 1992; 166:1393-400.
15. ter Kuile FO, Dolan G, Nosten F, et al. Halofantrine versus mefloquine in treatment of multidrug-resistant falciparum malaria. Lancet 1993; 341:1044-9.
16. Nosten F, ter Kuile FO, Luxemburger C, et al. Cardiac effects of antimalarial treatment with halofantrine. Lancet 1993;341:1054-6.
17. Watt G, Loesuttivibool L, Shanks GD, et al. Quinine with tetracycline for the treatment of drug-resistant falciparum malaria in Thailand. Am J Trop Med Hyg 1992;47:108-11.
18. Hien TT, White NJ. Qinghaosu. Lancet 1993;341:603-8.
19. Looareesuwan S. Overview of clinical studies on artemisinin derivatives in Thailand. Trans R Soc Trop Med Hyg 1994;88:Suppl 1:S9-S11.
20. Looareesuwan S, Viravan C, Vanijanonta S, et al. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 1992;339:821-4.
21. Nosten F, Luxemburger C, ter Kuile FO, et al. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J Infect Dis 1994;170:971-7. [Erratum, J Infect Dis 1995;171:519.]
22. The role of artemisinin and its derivatives in the current treatment of malaria (1994-1995): report of an informal consultation convened by WHO in Geneva, 27-29 September 1993. Geneva: World Health Organization, 1994. (WHO/MAL/94.1067.)
23. World Health Organization, Division of Control of Tropical Diseases. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990;84: Suppl 2:1-65.
24. Molyneux ME, Taylor TE, Wirima JJ, Borgstein A. Clinical features and prognostic indicators in paediatric cerebral malaria: a study of 131 comatose Malawian children. Q J Med 1989;71:441-59.
25. Marsh K, Forster D, Waruiru C, et al. Indicators of life-threatening malaria in African children. N Engl J Med 1995;332:1399-404.
26. Trang TTM, Phu NH, Vinh H, et al. Acute renal failure in patients with severe falciparum malaria. Clin Infect Dis 1992;15:874-80.
27. White NJ, Warrell DA, Chanthavanich P, et al. Severe hypoglycemia and hyperinsulinemia in felciparum malaria. N Engl J Med 1983;309:61-6.
28. White NJ, Miller KD, Marsh K, et al. Hypoglycaemia in African children with severe malaria. Lancet 1987;1:708-11.
29. Lackritz EM, Campbell CC, Ruebush TK II, et al. Effect of blood transfusion on survival among children in a Kenyan hospital. Lancet 1992; 340:524-8.
30. Mabey DCW, Brown A, Greenwood BM. Plasmodium falciparum malaria and Salmonella infections in Gambian children. J Infect Dis 1987;155: 1319-21.
31. White NJ, Krishna S, Waller D, Craddock C, Kwiatkowski D, Brewster D. Open comparison of intramuscular chloroquine and quinine in children with severe chloroquine-sensitive falciparum malaria. Lancet 1989;2:1313-6.
32. White NJ, Miller KD, Churchill FC, et al. Chloroquine treatment of severe malaria in children: pharmacokinetics, toxicity, and new dosage recommendations. N Engl J Med 1988;319:1493-500.
33. Miller KD, Greenberg AE, Campbell CC. Treatment of severe malaria in the United States with a continuous infusion of quinidine giuconate and exchange transfusion. N Engl J Med 1989;321:65-70.
34. Okitolonda W, Delacollette C, Malengreau M, Henquin JC. High incidence of hypoglycaemia in African patients treated with intravenous quinine for severe malaria. BMJ 1987;295:716-8.
35. Looareesuwan S, Phillips RE, White NJ, et al. Quinine and severe falciparum malaria in late pregnancy. Lancet 1985;2:4-8.
36. Karbwang J, Davis TME, Looareesuwan S, Molunto P, Bunnag D, White NJ. A comparison of the pharmacokinetic and pharmacodynamic properties of quinine and quinidine in healthy Thai males. Br J Clin Pharmacol 1993;35:265-71.
37. White NJ, Looareesuwan S, Warrell DA, Warrell MJ, Bunnag D, Harinasuta T. Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am J Med 1982;73:564-72.
38. Silamut K, Molunto P, Ho M, Davis TM, White NJ. Alpha I-acid glycoprotein (orosomucoid) and plasma protein binding of quinine in falciparum malaria. Br J Clin Pharmacol 1991;32:311-5.
39. Winstanley P, Newton C, Watkins W, et al. Towards optimal regimens of parenteral quinine for young African children with cerebral malaria: the importance of unbound quinine concentration. Trans R Soc Trop Med Hyg 1993;87:201-6.
40. Waller D, Krishna S, Craddock C, et al. The pharmacokinetic properties of intramuscular quinine in Gambian children with severe falciparum malaria. Trans R Soc Trop Med Hyg 1990;84:488-91.
41. Pasvol G, Newton CRJC, Winstanley PA, et al. Quinine treatment of severe falciparam malaria in African children: a randomized comparison of three regimens. Am J Trop Med Hyg 1991;45:702-13.
42. Hien TT, Arnold K, Vinh H, et al. Comparison of artemisinin suppositories with intravenous artesunate and intravenous quinine in the treatment of cerebral malaria. Trans R Soc Trop Med Hyg 1992;86:582-3.
43. ter Kuile F, White NJ, Holloway P, Pasvol G, Krishna S. Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria. Exp Parasitol 1993;76:85-95.
44. Udomsangpetch R, Pipitaporn B, Krishna S, et al. Antimalarial drugs reduce cytoadherence and resetting of Plasmodium falciparum. J Infect Dis 1996;173;691-8.
45. Boele van Hensbroek M, Onyiorah E, Jaffar S, et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996; 335:69-75.
46. Hien TT, Day NPJ, Phu NH, et al. A controlled trial of artemether or quinine in Vietnamese adults with severe falciparum malaria. N Engl J Med 1996;335:76-83.
47. Brewer TG, Peggins JO, Grate SJ, et al. Neurotoxicity in animals due to arteether and artemether. Trans R Soc Trop Med Hyg 1994;88:Suppl 1: S33-S36.
48. Looareesuwan S, Phillips RE, Karbwang J, White NJ, Flegg PJ, Warrell DA. Plasmodium falciparum hyperparasitaemia: use of exchange transfusion in seven patients and a review of the literature. Q J Med 1990; 75:471-81.
49. Van den Ende J, Moorkens G, Van Gompel A, et al. Twelve patients with severe malaria treated with partial exchange transfusion: comparison between mathematically predicted and observed effect on parasitaemia. Trop Geogr Med 1994;46:340-5.